article thumbnail

Chemotherapy

RX Note

Ministry of Health Systemic Therapy Protocol 2016 Ministry of Health Systemic Therapy Protocol focuses on chemotherapy and targeted therapies used in the treatment of solid tumours. However, in reality, chemotherapy regimen is not very different from how we manage a hypertension or diabetes mellitus.

article thumbnail

Diabetes Drug Shortages and Fake Ozempic

National Association of Boards of Pharmacy

Injectable diabetes medications including semaglutide, namely Wegovy and Ozempic, have been in shortage since 2022 , limiting patient access to the drug across the nation. Many other drugs have appeared on FDA’s shortage list in the past few years, including ADHD medications, chemotherapy treatments, and even antibiotics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties

STAT

The techs who were queried identified chemotherapies; ADHD medicines; three drugs for weight loss and diabetes — Mounjaro, Ozempic, and Wegovy — and local anesthetics such as lidocaine as the top drugs experiencing shortages.

article thumbnail

Survey: 72% of Pharmacy Technicians’ Workflow Affected by Drug Shortages

Pharmacy Times

Chemotherapy, medication for attention deficit/hyperactivity disorder, glucagon-like peptide-1 agonists for weight loss and diabetes, and local anesthetics were among the drugs most affected by shortages.

article thumbnail

Dry Eye

RX Note

Historically, dry eye disease (DED) has been classified into 2 general groups: Aqueous deficient DED Decreased tear production due to Sjogren's syndrome, older age and diabetes mellitus. Medical conditions Patients with rheumatoid arthritis , diabetes or thyroid problems are more likely to experience dry eyes.

article thumbnail

Bayer triples sales forecast for prostate cancer drug Nubeqa

pharmaphorum

The study showed that adding Nubeqa to standard therapy with anti-androgen drugs and chemotherapy with docetaxel reduced the risk of dying by 32.5% compared to standard therapy alone. There was also a big increase in the duration of response, from a media of just under 17 months to 41 months.

article thumbnail

Chasing rivals, Bayer files Nubeqa for new prostate cancer use

pharmaphorum

When this happens, the first line of drug treatment for hormone-sensitive tumours is ADT, with chemotherapy layered on top if needed. Around 95% of prostate cancers are localised at diagnosis and treated with surgery or radiotherapy, but tend to relapse.